Back to Results
First PageMeta Content
Cancer immunotherapy / Immunotherapy / Skin cancer / Michael Milken / Breast cancer / Medicine / Oncology / Melanoma


MRA PRAISES DRUG APPROVAL IN JAPAN AS “GAME-CHANGING” WASHINGTON, D.C., July 7, 2014 – The Melanoma Research Alliance (MRA) today applauded the news that Japanese drug regulators granted approval to nivolumab, mark
Add to Reading List

Document Date: 2014-07-07 16:16:18

Open Document

File Size: 84,69 KB

Share Result on Facebook

City

WASHINGTON / D.C. / /

Company

Ono Pharmaceutical / Anreder & Company / /

Country

Japan / United States / /

Currency

USD / /

/

Event

FDA Phase / /

Facility

Milken Institute / /

IndustryTerm

melanoma treatment / care for melanoma / /

MedicalCondition

leukemia / tumor / unresectable melanoma / cancer / lymphoma / skin cancer / grant-giving disease / melanoma / lung cancer / /

MedicalTreatment

immunotherapy / /

Organization

Melanoma Research Alliance MRA / Melanoma Research Alliance / Milken Institute / /

Person

Leon Black / Wendy Selig / Debra Black / Michael Wichman / /

/

Position

President and CEO / /

Product

PRAISES DRUG / PD-1 / /

Technology

Genetic Engineering / Biotechnology / /

URL

www.CureMelanoma.org / /

SocialTag